Literature DB >> 15993084

Branched aminoglycosides: biochemical studies and antibacterial activity of neomycin B derivatives.

Mariana Hainrichson1, Varvara Pokrovskaya, Dalia Shallom-Shezifi, Micha Fridman, Valery Belakhov, Dina Shachar, Sima Yaron, Timor Baasov.   

Abstract

The C5''-OH group in neomycin B was glycosylated with a variety of mono- and di-saccharides to probe the effect of introduction of additional binding elements on antibacterial activity and interaction with the aminoglycosides modifying enzyme APH(3')-IIIa. The designed structures show antibacterial activity superior to that of neomycin B against pathogenic and resistant strains, while in parallel they demonstrate poor substrate activity with APH(3')-IIIa.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15993084     DOI: 10.1016/j.bmc.2005.05.058

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  11 in total

1.  Overexpression and initial characterization of the chromosomal aminoglycoside 3'-O-phosphotransferase APH(3')-IIb from Pseudomonas aeruginosa.

Authors:  Mariana Hainrichson; Orit Yaniv; Marina Cherniavsky; Igor Nudelman; Dalia Shallom-Shezifi; Sima Yaron; Timor Baasov
Journal:  Antimicrob Agents Chemother       Date:  2006-11-06       Impact factor: 5.191

2.  N6', N6''', and O4' Modifications to Neomycin Affect Ribosomal Selectivity without Compromising Antibacterial Activity.

Authors:  Girish C Sati; Dimitri Shcherbakov; Sven N Hobbie; Andrea Vasella; Erik C Böttger; David Crich
Journal:  ACS Infect Dis       Date:  2017-04-06       Impact factor: 5.084

Review 3.  Comprehensive review of chemical strategies for the preparation of new aminoglycosides and their biological activities.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Chem Soc Rev       Date:  2018-02-19       Impact factor: 54.564

Review 4.  New developments in aminoglycoside therapy and ototoxicity.

Authors:  Jing Xie; Andra E Talaska; Jochen Schacht
Journal:  Hear Res       Date:  2011-05-27       Impact factor: 3.208

5.  Selectively guanidinylated aminoglycosides as antibiotics.

Authors:  Richard J Fair; Mary E Hensler; Wdee Thienphrapa; Quang N Dam; Victor Nizet; Yitzhak Tor
Journal:  ChemMedChem       Date:  2012-05-25       Impact factor: 3.466

6.  Rapid synthesis, RNA binding, and antibacterial screening of a peptidic-aminosugar (PA) library.

Authors:  Liuwei Jiang; Derrick Watkins; Yi Jin; Changjun Gong; Ada King; Arren Z Washington; Keith D Green; Sylvie Garneau-Tsodikova; Adegboyega K Oyelere; Dev P Arya
Journal:  ACS Chem Biol       Date:  2015-02-23       Impact factor: 5.100

Review 7.  New treatment options for hearing loss.

Authors:  Ulrich Müller; Peter G Barr-Gillespie
Journal:  Nat Rev Drug Discov       Date:  2015-03-20       Impact factor: 84.694

8.  Surprising alteration of antibacterial activity of 5"-modified neomycin against resistant bacteria.

Authors:  Jianjun Zhang; Fang-I Chiang; Long Wu; Przemyslaw Greg Czyryca; Ding Li; Cheng-Wei Tom Chang
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

9.  Cationic polyamines inhibit anthrax lethal factor protease.

Authors:  Mark Evan Goldman; Lynne Cregar; Dominique Nguyen; Ondrej Simo; Sean O'Malley; Tom Humphreys
Journal:  BMC Pharmacol       Date:  2006-06-08

Review 10.  Overcoming Aminoglycoside Enzymatic Resistance: Design of Novel Antibiotics and Inhibitors.

Authors:  Sandra G Zárate; M Luisa De la Cruz Claure; Raúl Benito-Arenas; Julia Revuelta; Andrés G Santana; Agatha Bastida
Journal:  Molecules       Date:  2018-01-30       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.